Immune checkpoint inhibitor-related adrenal hypofunction and Psoriasisby induced by tislelizumab: A case report and review of literature
Article in Medicine (March 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Immunotherapy-Induced Hypophysitis Following Treatment With Tislelizumab in an Elderly Patient With Bladder Cancer and Prostate Cancer: A Case Report
Article in Cureus (December 2023)
Immune-related adverse events with severe pain and ureteral expansion as the main manifestations: a case report of tislelizumab-induced ureteritis/cystitis and review of the literature
Article in Frontiers in Immunology (October 2023)